Transcription factor NF-κB and inhibitor IκBα are localized in macrophages in active multiple sclerosis lesions

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 2, 1998, Pages 168-178

  Gveric, Djordje ^a   Kaltschmidt, Christian ^b   Cuzner, M Louise ^a   Newcombe, Jia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

c Rel; I B ; Macrophages; Microglia; Multiple sclerosis; NF B; RelA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INHIBITOR PROTEIN IKBA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0031951041     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199802000-00008     Document Type: Article

References (44)

1. Cuzner ML. Molecular biology of microglia. Russel WC, ed. In: Molecular biology of multiple sclerosis. Wiley and Sons; 1997:97-120
2. Baeuerle PA, Henkel T. Function and activation of NF-KB in the immune system. Ann Rev Immunol 1994;12:141-79
3. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS. IKB interacts with the nuclear-localisation sequences of the subunits of NF-KB - a mechanism for cytoplasmic retention. Gen Dev 1992;6:1899-1913
4. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor-alpha transcription in macrophages - involvement of four KB-like motifs and of constitutive and inducible forms of NF-KB. Mol Cell Biol 1990;10:1498-1506
5. Miyamoto S, Chiao P, Verma I. Enhanced IKBα degradation is responsible for constitutive NF-KB activity in mature murine B cell lines. Mol Cell Biol 1994;14:3276-82
6. Beg AA, Finco TS, Nantermet PV, Baldwin AS. Tumor-necrosis-factor and interleukin-1 lead to phosphorylation and loss of IKBα - a mechanism for NF-KB activation. Mol Cell Biol 1993; 13:3301-10
7. Le Bail O, Schmidt-Ullrich R, Israel A. Promoter analysis of the gene encoding the IKBα /MAD-3 inhibitor of NF-KB: Positive regulation by members of the rel/ NF-KB family. Embo J 1993;12:5043-49
8. Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-KB controls expression of inhibitor IKBα-evidence for an inducible autoregulatory pathway. Science 1993;259:1912-15
9. Romano MF, Lamberti A, Petrella A, Bisogni R, Tassone P, et al. IL-10 inhibits NF-KB/rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol 1996;156:2119-23
10. Scheinmann RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IKBα in mediation of immunosuppresion by glucocorticoids. Science 1995;270:283-86
11. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M. Immunosuppresion by glucocorticoids - inhibition of NF-KB activity through induction of IKB synthesis. Science 1995;270:286-90
12. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-KB activity in neurons. Mol Cell Biol 1994; 14:3981-92
13. Moynagh DA, Williams DC, D'Neill LAJ. Interleukin-1 activates transcription factor NF-KB in glial cells. Biochem J 1993;294:343-47
14. Diehl JA, Tong W, Sun G, Hannink M. Tumor necrosis factor-alpha-dependent activation of a RelA homodimer in astrocytes. J Biol Chem 1995;270:2703-7
15. O'Neill LAJ, Kaltschmidt C. NF-KB: A crucial transcription factor for glial and neuronal cell function. TINS 1997;20:252-58
16. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Baeuerle PA. Transcription factor NF-KB is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol 1994;55:99-106
17. Dollard SC, James HJ, Sharer LR, Epstein LG, Gelbard HA, Dewhurst S. Activation of NF-KB in brains from children with HIV-1 encephalitis. Neuropathol Appl Neurobiol 1995;21:518-28
18. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of NF-KB in atherogenesis. Exp Physiol 1997;82:297-304
19. Handel ML, McMorrow LB, Gravallese EM. NF-KB in rheumatoid synovium - localisation of p50 and p65. Arth Rheum 1995;38:1762-70
20. Terai K, Matsuo A, McGeer EG, McGeer PL. Enhancement of immunoreactivity for NF-KB in human cerebral infarctions. Brain Res 1996;739:343-49
21. Newcombe J, Cuzner ML. Organisation and research application of the UK Multiple Sclerosis Society Tissue Bank. In: Cruz-Sanchez FF, Tolosa E, eds. How to run a brain bank. J Neural Transm 1993 (Suppl);39:155-63
22. Li H, Newcombe J, Groome NP, Cuzner ML. Characterisation and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993;19:214-33
23. Kaltschmidt C, Kaltschmidt B, Henkel T. Stockinger H, Baeuerle PA. Selective recognition of the activated form of transcription factor NF-KB by a monoclonal antibody. Biol Chem Hoppe-Seyler 1995;376:9-16
24. Newcombe J, Meeson A, Cuzner ML. Immunocytochemical characterisation of primary glial cell cultures from normal adult human brain. Neuropathol Appl Neurobiol 1988;14:453-65
25. Newcombe J, Cuzner ML. Monoclonal antibody 14E identifies the oligodendrocyte cell body in normal adult human and rat white matter. J Neuroimmunol 1988;19:11-20
26. Li H. Distribution and phenotypic characteristics of mononuclear phagocytes in multiple sclerosis plaques. PhD Thesis, University of London, 1994
27. Selmaj K, Raine CS, Cannella B, Brosnan CF Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-54
28. Woodrofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridisation. Cytokine 1993;5:583-88
29. Kaul N, Forman HJ. Activation of NF-KB by the respiratory burst of macrophages. Free Rad Biol Med 1996;21:401-5
30. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-KB is activated in primary neurons by amyloid-β peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc Natl Acad Sci USA 1997; 94:2624-47
31. van der Laan LJW, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-a and nitric oxide. J Neuroimmunol 1996;70:145-52
32. Irani DN, Lin KI, Griffin DE. Regulation of brain-derived T cells during acute central nervous system inflammation. J Immunol 1997;158:2318-26
33. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li RL, Tarlington D, Gerondakis S. Mice lacking the c-Rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin2 expression. Gen Dev 1995;9:1965-77
34. Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlink JPY, Grumont RJ. Rel deficient T cells exhibit defect in the production of interleukin-3 and granulocyte-macrophage colony stimulating factor. Proc Natl Acad Sci USA 1996;93:3405-9
35. Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. The c-rel protooncogene product represses NF-kB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc Natl Acad Sci USA 1993;90:1023-27
36. Zabel U, Henkel T, Suva MD, Baeuerle PA. Nuclear uptake control of NF-KB by MAD-3, an IKB protein present in the nucleus. Embo J 1993;12:201-11
37. Zabel U, Baeuerle PA. Purified human IKB can rapidly dissociate the complex of the NF-KB transcription factor with its cognate DNA. Cell 1990;61:255-65
38. Arenzana-Seisdedos F, Thompson J. Rodriguez MS, Bachelerie R Thomas D, Hay RT. Inducible nuclear expression of newly synthesised IKBα negatively regulates DNA-binding and transcriptional activities of NF-KB. Mol Cell Biol 1995;15:2689-96
39. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C. Nuclear localisation of IKBα promotes active transport of NF-KB from the nucleus to the cytoplasm. J Cell Sci 1997;110:369-78
40. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson JA, Mondai K, Ralph P, Baldwin AS. Characterisation of an immediate-early gene induced in adherent monocytes that encodes IKB-like activity. Cell 1991;65:1281-89
41. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-KB. EMBO J 1991; 10:1817-25
42. Selmaj K, Raine CS, Farooq M, et al. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 1991;147:1522-29
43. van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNFα-induced apoptosis by NF-KB. Science 1996;274:787-89
44. Newcombe J, Li H, Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: Implications for pathogenesis. Neuropathol Appl Neurobiol 1994;20:152-62